Literature DB >> 1559775

EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts.

S E Wilson1, Y G He, S A Lloyd.   

Abstract

We sought to determine whether human corneal epithelial cells and stromal fibroblasts synthesize messenger RNAs (mRNA) coding for epidermal growth factor (EGF), EGF receptor, basic fibroblast growth factor (basic FGF), transforming growth factor-beta 1 (TGF-beta 1), and interleukin-1 alpha (IL-1 alpha). Total cellular RNA was extracted from cultured stromal fibroblasts and ex vivo and cultured corneal epithelial cells. Oligo dt-primed complementary DNA (cDNA) was synthesized from each RNA sample. The polymerase chain reaction (PCR) was used to amplify sequences for EGF, EGF receptor, basic FGF, TGF-beta 1, IL-1 alpha, and beta actin from cDNA samples from each cell type. Southern blots of the PCR products were probed with oligonucleotides complementary to internal sequences within each of the amplified products. The amplification products were shown to be specific. For each modulator, the amplification product of the expected size was identified with at least one specific, alternative amplification product. The alternative splicing products suggest that there may be alternative mRNA splicing for each of the modulators studied. Differences were noted in the IL-1 alpha specific amplification products in stromal fibroblasts compared to corneal epithelial cells. EGF and EGF receptor mRNA production in human corneal epithelial cells and stromal fibroblasts suggest an autocrine role for EGF in the physiology of each of these cell types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559775

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells.

Authors:  V Holán; A Vítová; J Pindjáková; M Krulová; A Zajícová; M Filipec
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing.

Authors:  Jiawei Lu; Ling Wang; Wei Dai; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 3.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

Review 4.  Stress-induced corneal epithelial apoptosis mediated by K+ channel activation.

Authors:  Luo Lu
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

5.  The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes.

Authors:  S Pancholi; A Tullo; A Khaliq; D Foreman; M Boulton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

Review 6.  Regulation and clinical implications of corneal epithelial stem cells.

Authors:  S C Tseng
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  Limbal epithelial stem-microenvironmental alteration leads to pterygium development.

Authors:  Prosun Das; Arjun Gokani; Ketaki Bagchi; Gautam Bhaduri; Samaresh Chaudhuri; Sujata Law
Journal:  Mol Cell Biochem       Date:  2015-01-06       Impact factor: 3.396

8.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Immunolocalization of interleukin-1 alpha in rat mandibular molars and its enhancement after in vivo injection of epidermal growth factor.

Authors:  G E Wise; F Lin; L Zhao
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

10.  Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas.

Authors:  Fang Bian; Flavia S A Pelegrino; Stephen C Pflugfelder; Eugene A Volpe; De-Quan Li; Cintia S de Paiva
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.